![]()
|
|
||||||||
(Received for publication, May 30, 1996, and in revised form, August 19, 1996)
From the Departments of Neurology and Molecular Biology & Pharmacology, Washington University School of Medicine,
St. Louis, Missouri 63110
Nerve growth factor (NGF) promotes mast cell
survival in vitro (Horigome, K., Bullock, E. D., and
Johnson, E. M., Jr. (1994) J. Biol. Chem. 269, 2695-2702). NGF survival promotion is cell
density-dependent, and conditioned medium experiments have
shown that NGF increases the production of an autocrine mast cell
survival activity. Cytokines are potential candidates for autocrine
survival factors. In rat peritoneal mast cells (RPMC), NGF caused an
increase in the messenger RNAs for interleukin (IL)-3, IL-4, IL-10,
tumor necrosis factor-
Volume 271, Number 44,
Issue of November 1, 1996
pp. 27500-27508
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
POTENTIAL ROLE IN SURVIVAL PROMOTION
, and granulocyte-macrophage
colony-stimulating factor. This induction was NGF
dose-dependent, was blocked by NGF-neutralizing antibodies,
and was not observed in the non-mast peritoneal cell population. The
immunosuppressive agent, cyclosporin A, blocked both cytokine induction
and NGF-activated survival promotion but not survival promotion
activated by IL-3 or stem cell factor, suggesting that NGF enhanced
RPMC survival by increasing cytokine production. We also examine the
effects of NGF on the expression levels of some members of the
bcl-2 family and the interleukin-1
-converting
enzyme-like cysteine protease families. NGF markedly increased
bcl-2 expression but had little or no effect on the other
genes studied. The induction of bcl-2 mRNA by NGF was
not blocked by cyclosporin A. These data suggest that induced cytokine
gene expression but not increased expression of bcl-2
mediates NGF-survival promotion in RPMC.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Thacker, A. K. Clark, F. Marchand, and S. B. McMahon Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules Anesth. Analg., September 1, 2007; 105(3): 838 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moller, J. Alfredsson, M. Engstrom, H. Wootz, Z. Xiang, J. Lennartsson, J.-I. Jonsson, and G. Nilsson Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim Blood, August 15, 2005; 106(4): 1330 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Coppola, C. A. Barrick, E. A. Southon, A. Celeste, K. Wang, B. Chen, E.-B. Haddad, J. Yin, A. Nussenzweig, A. Subramaniam, et al. Ablation of TrkA function in the immune system causes B cell abnormalities Development, October 15, 2004; 131(20): 5185 - 5195. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Freund, F. Pons, V. Joly, E. Mathieu, N. Martinet, and N. Frossard Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions Eur. Respir. J., August 1, 2002; 20(2): 458 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawamoto, J. Aoki, A. Tanaka, A. Itakura, H. Hosono, H. Arai, Y. Kiso, and H. Matsuda Nerve Growth Factor Activates Mast Cells Through the Collaborative Interaction with Lysophosphatidylserine Expressed on the Membrane Surface of Activated Platelets J. Immunol., June 15, 2002; 168(12): 6412 - 6419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiang, A. A. Ahmed, C. Moller, K.-i. Nakayama, S. Hatakeyama, and G. Nilsson Essential Role of the Prosurvival bcl-2 Homologue A1 in Mast Cell Survival After Allergic Activation J. Exp. Med., November 26, 2001; 194(11): 1561 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Olgart and N. Frossard Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids Eur. Respir. J., July 1, 2001; 18(1): 115 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi The Sympathetic Nerve---An Integrative Interface between Two Supersystems: The Brain and the Immune System Pharmacol. Rev., December 1, 2000; 52(4): 595 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. la Sala, S. Corinti, M. Federici, H. U. Saragovi, and G. Girolomoni Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis J. Leukoc. Biol., July 1, 2000; 68(1): 104 - 110. [Abstract] [Full Text] |
||||
![]() |
C. L. Afonso, E. R. Tulman, Z. Lu, L. Zsak, G. F. Kutish, and D. L. Rock The Genome of Fowlpox Virus J. Virol., April 15, 2000; 74(8): 3815 - 3831. [Abstract] [Full Text] |
||||
![]() |
A. Druilhe, B. Wallaert, A. Tsicopoulos, J.-R. L. e Silva, I. Tillie-Leblond, A.-B. Tonnel, and M. Pretolani Apoptosis, Proliferation, and Expression of Bcl-2, Fas, and Fas Ligand in Bronchial Biopsies from Asthmatics Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 747 - 757. [Abstract] [Full Text] |
||||
![]() |
A. Masuda, T. Matsuguchi, K. Yamaki, T. Hayakawa, and Y. Yoshikai Interleukin-15 Prevents Mouse Mast Cell Apoptosis through STAT6-mediated Bcl-xL Expression J. Biol. Chem., July 6, 2001; 276(28): 26107 - 26113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |